Clinical trial
Evaluate Safety and Efficacy of ABT-335 in Combination With Rosuvastatin Calcium…
NCT00300482 · Abbott, Industry · Completed
Key facts
| NCT number | NCT00300482 |
|---|---|
| Title | Evaluate Safety and Efficacy of ABT-335 in Combination With Rosuvastatin Calcium in Subjects With Multiple Abnormal Lipid Levels in the Blood |
| Official title | A Multicenter, Randomized, Double-Blind, Prospective Study Comparing the Safety and Efficacy of Fenofibric Acid and Rosuvastatin Calcium Combination Therapy to Fenofibric Acid and Rosuvastatin Calcium Monotherapy in Subjects With Mixed Dyslipidemia |
| Lead sponsor | Abbott, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Dyslipidemia, Coronary Heart Disease, Mixed Dyslipidemia |
| Intervention type | Drug |
| Interventions | ABT-335, Rosuvastatin Calcium, Placebo |
| Enrollment | 1,445 |
| Start date | Mar 1, 2006 |
| Primary completion | Dec 1, 2006 |
| First posted | Mar 9, 2006 |
| Last update posted | Jun 10, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: